We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Allurion Technologies Inc | NYSE:ALUR | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.0119 | -3.77% | 0.3034 | 0.337 | 0.30 | 0.31 | 223,754 | 01:00:00 |
From Dec 2023 to Dec 2024
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences:
About Jefferies Global Healthcare Conference
Allurion’s Chief Executive Officer, Shantanu Gaur, and Chief Financial Officer, Chris Geberth, will participate in a fireside chat during the Jefferies Global Healthcare Conference, which will be held in New York City on June 5–6, 2024. Management will also participate in 1x1 meetings.
The fireside chat is scheduled for Wednesday, June 5, 2024 at 1:30 p.m. Eastern Time, and will be accessible via a live webcast here. The webcast replay will be available after the conclusion of the live presentation on the Company’s website.
About Sidoti Small Cap Virtual Conference
Allurion’s Chief Executive Officer, Shantanu Gaur, and Chief Financial Officer, Chris Geberth, will deliver a presentation during the Sidoti Small Cap Virtual Conference, which will be held virtually on June 12-13, 2024. Management will also participate in 1x1 meetings.
The presentation is scheduled for Thursday, June 13, 2024 at 10:00 a.m. Eastern Time, and will be accessible via a live webcast that you can find on the Company’s website. The webcast replay will also be available after the conclusion of the live presentation on the Company’s website.
About Allurion
Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Coach Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.
For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.
Allurion is a trademark of Allurion Technologies, Inc. in the United States and countries around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529694987/en/
Global Media: Cedric Damour PR Manager +33 7 84 21 02 20 cdamour@allurion.com Investors: Mike Cavanaugh, Investor Relations ICR Westwicke (617) 877-9641 mike.cavanaugh@westwicke.com
1 Year Allurion Technologies Chart |
1 Month Allurion Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
